web statistics
PRESS ROOM        PUBLICATIONS       CAREERS
Investor Relations & News
KineMed  ► Investor Relations & News > Press Room > KineMed announces license agreement to develop late-stage synthetic Ghrelin

Forthcoming Events

Latest News

KineMed announces license agreement to develop late-stage synthetic Ghrelin

KineMed announces license agreement to develop late-stage synthetic Ghrelin

Videos & Webcasts


www.kinemed.com

 Copyright © 2014 KineMed, Inc.  |  All Rights Reserved  |  Privacy  |  Terms & Conditions